András Bikov1, László Kunos1, Éva Pállinger2, Zsófia Lázár1, Adrián Kis1, Gábor Horváth1, György Losonczy1, Zsolt István Komlósi3. 1. Department of Pulmonology, Semmelweis University, Diós árok 1/C, Budapest, 1125, Hungary. 2. Department of Genetics, Cell- and Immunobiology, Semmelweis University, Nagyvárad tér 4, Budapest, 1089, Hungary. 3. Department of Pulmonology, Semmelweis University, Diós árok 1/C, Budapest, 1125, Hungary. drkomlo@yahoo.com.
Abstract
PURPOSE: Microvesicles (MVs) have been implicated in the pathomechanism of obstructive sleep apnoea (OSA); however, the results are inconsistent, possibly due to an unrevealed temporal variation in circulating MV levels. We aimed to investigate the diurnal changes of MV fractions in OSA. METHODS: Peripheral blood was taken from 18 patients with OSA and 9 healthy subjects at different time points (11:00, 17:00, 21:00, 01:30 and 06:00). Samplings were repeated in nine OSA patients after 2 months of continuous positive airway pressure (CPAP) therapy. CD41+, CD62P+, glycophorin A+ and Annexin V+ MVs were determined with flow cytometry. Areas under the MV concentrations-time curves (AUC) were calculated and correlated with the severity of OSA. RESULTS: A significant diurnal variability of plasma CD41+ and Annexin V+ MVs was observed only in OSA with a marked peak at 17:00. There was a direct correlation between CD41+ MV AUCs and the severity of OSA. CPAP treatment reduced diurnal variability in both CD41+ and Annexin V+ MV levels. CONCLUSIONS: The relationship between the diurnal variability of CD41+ MVs and disease severity as well as the effect of CPAP treatment on MV levels support the role of MVs in the pathophysiology of OSA. More importantly, considering the significant diurnal variation in circulating MV levels, introduction of strict protocols for blood sampling is required for MV measurements.
PURPOSE: Microvesicles (MVs) have been implicated in the pathomechanism of obstructive sleep apnoea (OSA); however, the results are inconsistent, possibly due to an unrevealed temporal variation in circulating MV levels. We aimed to investigate the diurnal changes of MV fractions in OSA. METHODS: Peripheral blood was taken from 18 patients with OSA and 9 healthy subjects at different time points (11:00, 17:00, 21:00, 01:30 and 06:00). Samplings were repeated in nine OSA patients after 2 months of continuous positive airway pressure (CPAP) therapy. CD41+, CD62P+, glycophorin A+ and Annexin V+ MVs were determined with flow cytometry. Areas under the MV concentrations-time curves (AUC) were calculated and correlated with the severity of OSA. RESULTS: A significant diurnal variability of plasma CD41+ and Annexin V+ MVs was observed only in OSA with a marked peak at 17:00. There was a direct correlation between CD41+ MV AUCs and the severity of OSA. CPAP treatment reduced diurnal variability in both CD41+ and Annexin V+ MV levels. CONCLUSIONS: The relationship between the diurnal variability of CD41+ MVs and disease severity as well as the effect of CPAP treatment on MV levels support the role of MVs in the pathophysiology of OSA. More importantly, considering the significant diurnal variation in circulating MV levels, introduction of strict protocols for blood sampling is required for MV measurements.
Authors: P Marc van der Zee; Eva Biró; Yung Ko; Robbert J de Winter; C Erik Hack; Augueste Sturk; Rienk Nieuwland Journal: Clin Chem Date: 2006-01-26 Impact factor: 8.327
Authors: Michaela Diamant; Rienk Nieuwland; Renée F Pablo; Augueste Sturk; Jan W A Smit; Jasper K Radder Journal: Circulation Date: 2002-11-05 Impact factor: 29.690
Authors: Géza Tamás Szabó; Bettina Tarr; Krisztina Pálóczi; Katalin Éder; Eszter Lajkó; Ágnes Kittel; Sára Tóth; Bence György; Mária Pásztói; Andrea Németh; Xabier Osteikoetxea; Éva Pállinger; András Falus; Katalin Szabó-Taylor; Edit Irén Buzás Journal: Cell Mol Life Sci Date: 2014-04-06 Impact factor: 9.261
Authors: Clete A Kushida; Michael R Littner; Timothy Morgenthaler; Cathy A Alessi; Dennis Bailey; Jack Coleman; Leah Friedman; Max Hirshkowitz; Sheldon Kapen; Milton Kramer; Teofilo Lee-Chiong; Daniel L Loube; Judith Owens; Jeffrey P Pancer; Merrill Wise Journal: Sleep Date: 2005-04 Impact factor: 5.849
Authors: Daniela Cesselli; Pietro Parisse; Aneta Aleksova; Claudia Veneziano; Celeste Cervellin; Andrea Zanello; Antonio Paolo Beltrami Journal: Front Physiol Date: 2018-10-01 Impact factor: 4.566
Authors: P Horváth; Z Lázár; G Gálffy; R Puskás; L Kunos; Gy Losonczy; M Mészáros; Á D Tárnoki; D L Tárnoki; A Bikov Journal: Lung Date: 2020-01-02 Impact factor: 2.584
Authors: Anna Brzecka; Karolina Sarul; Tomasz Dyła; Marco Avila-Rodriguez; Ricardo Cabezas-Perez; Vladimir N Chubarev; Nina N Minyaeva; Sergey G Klochkov; Margarita E Neganova; Liudmila M Mikhaleva; Siva G Somasundaram; Cecil E Kirkland; Vadim V Tarasov; Gjumrakch Aliev Journal: Curr Genomics Date: 2020-09 Impact factor: 2.236